MMP9 and urinary bladder carcinoma: These proteins may not effect proangiogenic pathways in bladder cancer; they can however interact with IL-1α, IL-8, VEGF (vascular-endothelial growth factor), and MMP-9 (matrix metalloproteinase-9) to enhance tumorigenesis and tumor invasiveness.